Global cutaneous fibrosis treatment market will reach 723 million US$ by the end of 2025

Publisher: QYResearch

Published Date: 2019/7/29

The global cutaneous fibrosis treatment market has been steadily rising due to a high incidence of skin diseases. Diagnosis of skin disorders and disease due to cutaneous fibrosis, such as scleroderma, keloids, and hypertrophy scars is expected to boost market growth in the coming years. Market is also expected to be driven by the increasing number of clinical trials for better drugs and treatments. Improving investments in research and development have also created a positive impact on the global cutaneous fibrosis treatment market.

However, on the flip side, lack of awareness about this rare disease is projected to hamper the growth of the market. Delayed diagnosis of the disease is expected to act as a major restraint for the global cutaneous fibrosis treatment market.

The global cutaneous fibrosis treatment market is expected to reach US$723 mn by the end of 2025 from US$475 mn in 2018. During the forecast years of 2019 and 2025 the global market for cutaneous fibrosis is expected to register a CAGR of 6.2%.

Click to view the full report:

https://www.qyresearch.com/index/detail/1157366/global-cutaneous-fibrosis-treatment-market

This article was first released by QYResearch, if reproduced, please indicate the source.

Contact:press@qyresearch.com